Literature DB >> 8025714

Hypothalamo-preoptic histaminergic projections in sleep-wake control in the cat.

J S Lin1, K Sakai, M Jouvet.   

Abstract

Cats were chronically implanted with electrodes for polygraphic recordings and cannulae for intracerebral microinjections in order to study the functional role of histaminergic innervation of the preoptic-anterior hypothalamus in sleep-wake control. alpha-Fluoromethylhistidine (alpha FMH, 50 micrograms in 1 microliter), a specific inhibitor of the histamine-synthesizing enzyme, when injected bilaterally into the preoptic area, where numerous histaminergic fibres and terminal-like structures are present, caused a significant increase in deep slow wave sleep (S2) and paradoxical sleep (PS) and a decrease in wakefulness. In contrast, microinjections of histamine (5 or 30 micrograms in 1 microliter) in the same area dose-relatedly increased wakefulness and decreased both slow wave sleep and paradoxical sleep. The effects of histamine were reduced by pretreatment with mepyramine (1 mg/kg i.p.), a well known histamine H1 receptor antagonist, and were mimicked by a local injection of impromidine (1 microgram in 1 microliter), a potent histamine H2 receptor agonist. Microinjections of mepyramine alone (120 micrograms in 1 microliter) caused an increase in slow wave sleep. These results suggest that preoptic histaminergic innervation is involved in sleep-wake control and that the action might be mediated via both H1 and H2 receptors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8025714     DOI: 10.1111/j.1460-9568.1994.tb00306.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  22 in total

1.  Histamine regulates activities of neurons in the ventrolateral preoptic nucleus.

Authors:  Yu-Wei Liu; Jing Li; Jiang-Hong Ye
Journal:  J Physiol       Date:  2010-08-19       Impact factor: 5.182

2.  Connectivity of sleep- and wake-promoting regions of the human hypothalamus observed during resting wakefulness.

Authors:  Aaron D Boes; David Fischer; Joel C Geerling; Joel Bruss; Clifford B Saper; Michael D Fox
Journal:  Sleep       Date:  2018-09-01       Impact factor: 5.849

3.  Innervation of histaminergic tuberomammillary neurons by GABAergic and galaninergic neurons in the ventrolateral preoptic nucleus of the rat.

Authors:  J E Sherin; J K Elmquist; F Torrealba; C B Saper
Journal:  J Neurosci       Date:  1998-06-15       Impact factor: 6.167

Review 4.  Waking with the hypothalamus.

Authors:  Helmut L Haas; Jian-Sheng Lin
Journal:  Pflugers Arch       Date:  2011-07-28       Impact factor: 3.657

5.  Afferents to the ventrolateral preoptic nucleus.

Authors:  Thomas C Chou; Alvhild A Bjorkum; Stephanie E Gaus; Jun Lu; Thomas E Scammell; Clifford B Saper
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

6.  Hypothalamic Tuberomammillary Nucleus Neurons: Electrophysiological Diversity and Essential Role in Arousal Stability.

Authors:  Akie Fujita; Patricia Bonnavion; Miryam H Wilson; Laura E Mickelsen; Julien Bloit; Luis de Lecea; Alexander C Jackson
Journal:  J Neurosci       Date:  2017-09-05       Impact factor: 6.167

7.  Arousal effect of orexin A depends on activation of the histaminergic system.

Authors:  Z L Huang; W M Qu; W D Li; T Mochizuki; N Eguchi; T Watanabe; Y Urade; O Hayaishi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-07       Impact factor: 11.205

8.  Altered sleep-wake characteristics and lack of arousal response to H3 receptor antagonist in histamine H1 receptor knockout mice.

Authors:  Zhi-Li Huang; Takatoshi Mochizuki; Wei-Min Qu; Zong-Yuan Hong; Takeshi Watanabe; Yoshihiro Urade; Osamu Hayaishi
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-13       Impact factor: 11.205

9.  Acute wake-promoting actions of JNJ-5207852, a novel, diamine-based H3 antagonist.

Authors:  A J Barbier; C Berridge; C Dugovic; A D Laposky; S J Wilson; J Boggs; L Aluisio; B Lord; C Mazur; C M Pudiak; X Langlois; W Xiao; R Apodaca; N I Carruthers; T W Lovenberg
Journal:  Br J Pharmacol       Date:  2004-10-04       Impact factor: 8.739

10.  Modafinil in the treatment of excessive sleepiness.

Authors:  Jonathan R L Schwartz
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.